Resources
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Summary
The document summarises the national guidance for doctors assessing workers exposed to respirable crystalline silica dust.
National Guidance for doctors assessing workers exposed to respirable crystalline silica dust – Practice guide
This practice guide provides medical practitioners with guidance on identifying and assessing workers exposed to respirable crystalline silica dust, and carrying out health assessments and surveillance.
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix A – Exposure Risk Matrix
This exposure risk matrix assists medical practitioners assess workers exposed to respirable crystalline silica dust.
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix B – Shared decision making tool
This decision aid helps patients exposed to respirable crystalline silica (RCB) dust decide their next steps, including if they should keep working.
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix C – Modified MRC respiratory questionnaire
This questionnaire helps general practitioners assess workers exposed to respirable crystalline silica dust.
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix D – Modified MRC dyspnoea scale
This scale helps general practitioners assess workers exposed to respirable crystalline silica dust.
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Appendix E – Spirometry case study
This case study shows how to appropriately determine a change in spirometry over time in an individual exposed to respirable crystalline silica dust.
National guidance for doctors assessing workers exposed to respirable crystalline silica dust – Administrative report
This administrative report outlines how the National Dust Disease Taskforce developed national guidance for doctors assessing workers exposed to respirable crystalline silica dust.
enHealth guidance – Potential health effects of mould in the environment
This guidance from the Environmental Health Standing Committee (enHealth) provides recommendations from the House of Representatives Standing Committee on Health, Aged Care and Sport Inquiry into biotoxin-related illnesses in Australia.
enHealth guidance – Reducing exposure to metals in drinking water from plumbing products
This guidance from the Environmental Health Standing Committee (enHealth) provides advice to state and territory health departments about reducing exposure to lead and other metals from plumbing products.
enHealth guidance – Lead in drinking water from some plumbing products
This guidance from the Environmental Health Standing Committee (enHealth) highlights the health risks from lead exposure. It gives advice on how to minimise any potential exposures to lead leached out of plumbing fittings.
enHealth guidance – Risk communication principles
This guidance from the Environmental Health Standing Committee (enHealth) assists environmental health practitioners and public health agencies to better understand and prepare for communicating environmental health risks to the general public.
National Climate Resilience and Adaptation Strategy 2021–2025
The National Climate Resilience and Adaptation Strategy positions Australia to better anticipate, manage and adapt to climate change.
enHealth guidance – Environmental health incident management framework
This framework from the Environmental Health Standing Committee (enHealth) supports the National Health Emergency Response (NatHealth) arrangements during environmental health issues, such as emerging environmental contaminants or environmental health emergencies.
National Dust Disease Taskforce – Final report
This final report from the National Dust Disease Taskforce includes 7 recommendations to support a range of actions to improve worker health and safety from dust diseases.
National Dust Disease Taskforce communique – 7 June 2021
This communique summarises the eigth meeting of the National Dust Disease Taskforce, held on 7 June 2021.
Quantum Market Research dust disease research – Final report
This document outlines the results of research conducted for the National Dust Disease Taskforce. The research focussed on people with silicosis and other dust diseases to understand their health status, required supports, work history and their knowledge of prevention and control measures.
National Dust Disease Taskforce communique – 22 April 2021
This communique summarises the seventh meeting of the National Dust Disease Taskforce, held on 22 April 2021.
National Dust Disease Taskforce communique – 23 and 25 February 2021
This communique summarises the sixth meeting of the National Dust Disease Taskforce, held over 2 days – 23 and 25 February 2021.
National Dust Disease Taskforce – Consultation synthesis
National Dust Disease Taskforce – Consultation synthesis
enHealth guidance – Bushfire smoke and health – Summary of the current evidence
In response to the 2019–20 bushfire, this guidance from the Environmental Health Standing Committee (enHealth) provided a summary of the known health effects of bushfire smoke exposure.
Environmental Health Standing Committee (enHealth) – Strategic plan 2020–2023
This document sets out the strategic priorities of enHealth for the period 2020 to 2023.
Environmental Health Standing Committee (enHealth) – Work plan 2020–2023
The enHealth workplan 2020–2023 sets out the plan of action to achieve the priorities in the enHealth strategic plan.
National Dust Disease Taskforce communique – 3 November 2020
This communique summarises the fifth meeting of the National Dust Disease Taskforce, held on 3 November 2020.
National Dust Disease Taskforce communique – 12 August 2020
This communique summarises the fourth meeting of the National Dust Disease Taskforce, held on 12 August 2020.
Date last updated: